902OAn adaptive, biomarker directed platform study in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

902OAn adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies

Powles, T, Balar, A, Gravis, G, Jones, R, Ravaud, A, Florence, J, Grivas, P, Petrylak, D P, Galsky, M, Carles, J, Sridhar, S, Arkenau, H-T, Carroll, D, DeCesare, J, Mercier, F, Hodgson, D, Stone, J, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.001
Date:
October, 2019
File:
PDF, 109 KB
2019
Conversion to is in progress
Conversion to is failed